GW501516, also known as Cardarine, is a synthetic drug initially developed in the 1990s by pharmaceutical companies GlaxoSmithKline (GSK) and Ligand Pharmaceuticals. It belongs to a class of compounds called selective androgen receptor modulators (SARMs), although its specific action mechanism classifies it as a PPARδ (peroxisome proliferator-activated receptor delta) receptor agonist. The primary goal of its development was to treat metabolic and cardiovascular diseases, particularly due to its potential to regulate lipid and glucose metabolism.
Cardarine works by activating the PPARδ receptor, which plays a significant role in the regulation of fatty acid oxidation and energy expenditure. This activation results in increased endurance and stamina, making it appealing to athletes and bodybuilders. Studies have demonstrated that GW501516 can enhance physical performance and reduce recovery time after exercise. Additionally, it has been shown to improve insulin sensitivity and reduce inflammation, factors beneficial for managing conditions like obesity and type 2 diabetes. However, these potential benefits come with significant risks.
https://www.hormonerawsource.com/sarm-powders/sarms-powders/gw501516-powder-for-bodybuilding-cas-317318.html
